Cellid
KOSDAQ · Healthcare · ₩72B
₩2,350-3.29%
Price
2480.0원
2350.0원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩2.1B-35.8%
Operating Income-₩2.5B-54.7%
Net Income-₩19.0B-1182.6%
3/'26 vs prev quarter
Company Health
Market Cap₩72B
Operating Margin-99.4%
Cash on Hand169억원23.5% of market cap
Free Cash Flow-257억원-35.8% of market cap
Short Volume 2.3% · as of 26.09.11
Among 15 신약 개발 peers
LowMedianHigh
PSR6.7xmedian 10.3xPBR1.3xmedian 6.9xROE-51.0%median -51.0%
